Key terms
About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PFE news
Today
1:36am ET
Pfizer’s Hold Rating: Balancing Pipeline Potential with Clinical and Regulatory Uncertainties
Today
12:19am ET
Novavax (NASDAQ:NVAX): A Highly Speculative Value Trade in the Post-Pandemic Era
Yesterday
11:11am ET
Pfizer (NYSE:PFE) to Offload Haleon (NYSE:HLN) Shares Worth $2.5B
Mar 14
2:29pm ET
Caribou Biosciences (NASDAQ:CRBU): Recent Price Volatility May Offer Investors an Entry Point
Mar 13
5:14am ET
Pfizer announces EC grants marketing authorization for Prevenar 20
Mar 12
8:35am ET
Oric Pharmaceuticals price target raised to $17 from $14 at Oppenheimer
Mar 12
6:47am ET
Pfizer’s Adcetris shows improved survival in Phase 3 lymphoma trial
Mar 07
2:25am ET
Pfizer (PFE) Gets a Hold from J.P. Morgan
Mar 06
2:58pm ET
FDA approves Pfizer’s inotuzumab ozogamicin for pediatric ALL patients
Mar 06
12:11pm ET
ViiV Healthcare announces interim data of LATITUDE phase III trial
Mar 06
11:10am ET
ViiV Healthcare says interim data show superior efficacy of long-acting Cabenuva
Mar 05
11:39am ET
Healthcare Stocks Mostly In Retreat After New Task Force Announced
Mar 05
7:37am ET
Lava Therapeutics announces clinical development milestone achieved by Pfizer
Mar 04
11:15pm ET
Cantor Fitzgerald Sticks to Its Buy Rating for Pfizer (PFE)
Mar 04
10:05am ET
Pfizer call volume above normal and directionally bullish
Mar 04
7:30am ET
Citi views Pfizer oncology pipeline as undervalued
Mar 03
10:33am ET
Wells Fargo Keeps Their Hold Rating on Pfizer (PFE)
Mar 01
7:35am ET
Truist Financial Reaffirms Their Buy Rating on Pfizer (PFE)
Mar 01
7:06am ET
Pfizer (PFE) Gets a Hold from J.P. Morgan
Mar 01
6:18am ET
Pfizer’s Growth and Diversification: A Hold Rating Analysis by Terence Flynn
Feb 29
4:17pm ET
Cardiff Oncology doses first patient in CRDF-004 trial
Feb 29
1:25pm ET
Pfizer’s RSV Vaccine Abrysvo Poised for Significant Market Share Despite Competitors, Salveen Richter Recommends Buy
Feb 29
12:50pm ET
Pfizer to hold Oncology Innovation Day
Feb 29
11:27am ET
Olema Pharmaceuticals (NASDAQ:OLMA) Stock: Is There More Upside After a Remarkable Run in 2023?
Feb 29
8:31am ET
Pfizer announces top-line Abrysvo vaccine efficacy and safety data
Feb 29
4:55am ET
Pfizer to hold Oncology Innovation Day
Feb 28
10:10pm ET
Pfizer to hold Oncology Innovation Day
Feb 27
7:23am ET
Pfizer’s Oncology Strategy and Pipeline Development: A Hold Rating Amidst Transition and Long-Term Growth Prospects
Feb 23
4:39pm ET
Pfizer files automatic mixed securities shelf
Feb 23
9:37am ET
Block upgraded, Rivian downgraded: Wall Street’s top analyst calls
Feb 23
5:02am ET
Guggenheim starts Pfizer with Buy on reset expectations
Yesterday
5:49am ET
5 Reasons Why Buying This 6%-Yielding Dividend Stock Could Be a Brilliant Move
Mar 16
5:51am ET
Prediction: These Could Be the Best-Performing Value Stocks Through 2030
Mar 15
9:30am ET
Is Pfizer Stock a Millionaire Maker?
Mar 15
5:50am ET
Should Pfizer Acquire Viking Therapeutics to Take on Eli Lilly and Novo Nordisk in the Obesity Drug Market?
Mar 14
5:25am ET
3 Stocks I'm Adding to My Retirement Account in March
Mar 11
9:45am ET
2 Dirt Cheap Dividend Stocks to Buy and Hold
Mar 11
9:28am ET
3 Pharmaceutical Stocks to Buy Hand Over Fist in March
Mar 10
7:10pm ET
1 Bruised Dividend Stock to Buy While It's Cheap, and 1 to Avoid
Mar 10
9:35am ET
Have $2,000? 2 Magnificent Stocks Ready for a Bull Run
Mar 10
6:35am ET
3 Dividend Stocks to Buy Hand Over Fist in March
Mar 07
9:21am ET
1 Wall Street Analyst Thinks Pfizer Stock Is Going to $45. Is It a Buy Around $26?
No recent press releases are available for PFE
PFE Financials
Key terms
Ad Feedback
PFE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PFE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range